Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities

被引:8
作者
Bucher, K [1 ]
Besse, CA [1 ]
Kamau, SW [1 ]
Wunderli-Allenspach, H [1 ]
Krämer, SD [1 ]
机构
[1] Fed Inst Technol, ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, Zurich, Switzerland
关键词
rafts; ATPase activity; P-glycoprotein; screening assay; verapamil;
D O I
10.1007/s11095-004-1883-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. P-glycoprotein (P-gp), a membrane ATPase expelling many structurally unrelated compounds out of cells, is one of the major contributors to multidrug resistance. It is enriched in cold TritonX-100 insoluble membrane domains (i.e., rafts). The purpose of this work was to characterize the ATPase activities of raft preparations from P388 cells overexpressing P-gp (P388/ADR) or devoid of P-gp (P388) and to establish a P-gp-enriched screening system for P-gp-interfering compounds. Methods. Rafts were extracted with cold TritonX-100. The ATPase activity was characterized in 96-well plates using a fluorescence assay. Results. The ATPase activity per mg protein was about five times higher in P388/ADR rafts than in crude membranes. The anti-P-gp antibody C219 inhibited 20% of the activity in P388/ADR rafts but only about 10% of the activity in P388/ADR crude membranes and had no effect on the activity of P388 rafts. The known P-gp-activating compounds verapamil, progesterone, and valinomycin revealed the typical bell-shaped activity/concentration profiles in P388/ADR rafts, indicative for activation at low compound concentrations and inhibition at concentrations >1 0 to 100 mu M. The inhibitory effect was also observed in P388 rafts. Conclusions. Extracted rafts are rich in functional ATPases. Rafts from P-gp-overexpressing cells display P-gp-typical ATPase activity and provide an easy, P-gp-enriched screening system.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 49 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[3]   Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions [J].
Bakos, É ;
Evers, R ;
Sinkó, E ;
Váradi, A ;
Borst, P ;
Sarkadi, B .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :760-768
[4]   The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A [J].
Bilmen, JG ;
Wootton, LL ;
Michelangeli, F .
BIOCHEMICAL JOURNAL, 2002, 366 (01) :255-263
[5]   A step-by-step guide to non-linear regression analysis of experimental data using a Microsoft Excel spreadsheet [J].
Brown, AM .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2001, 65 (03) :191-200
[6]   SORTING OF GPI-ANCHORED PROTEINS TO GLYCOLIPID-ENRICHED MEMBRANE SUBDOMAINS DURING TRANSPORT TO THE APICAL CELL-SURFACE [J].
BROWN, DA ;
ROSE, JK .
CELL, 1992, 68 (03) :533-544
[7]   Cyclosporine A amplifies Ca2+ signaling pathway in LLC-PK1 cells through the inhibition of plasma membrane Ca2+ pump [J].
Calderaro, V ;
Boccellino, M ;
Cirillo, G ;
Quagliuolo, L ;
Cirillo, D ;
Giovane, A .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06) :1435-1442
[8]  
Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, V2
[9]   P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries [J].
Demeule, M ;
Jodoin, J ;
Gingras, D ;
Béliveau, R .
FEBS LETTERS, 2000, 466 (2-3) :219-224
[10]   Classification analysis of P-glycoprotein substrate specificity [J].
Didziapetris, R ;
Japertas, P ;
Avdeef, A ;
Petrauskas, A .
JOURNAL OF DRUG TARGETING, 2003, 11 (07) :391-406